News
8d
Zacks Investment Research on MSNAbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold?AbbVie ABBV stock has gained 16.1% so far this year compared with an increase of 4.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results